About Index Trending news
Analyze
Top 50 Pricing
Delenex Therapeutics

Delenex Therapeutics

Work at Delenex Therapeutics? Add yourself to this profile

Delenex Therapeutics

Delenex Therapeutics is engaged in developing therapeutic antibody fragments for diseases with high unmet needs.

Elsewhere

Alexa global traffic share

Latest funding
Venture capital (Series A)
$8,000,000
Employees

Team size

2
Locations
HQ
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Delenex Therapeutics makes some noise.